Melanoma

Patients with primary thyroid cancer who received radioactive iodine exhibited increased risk for melanoma and other nonkeratinocyte skin cancers, according to study results.

ORLANDO — A presentation at the American Society for Dermatologic Surgery Annual Meeting detailed new data that showcased the validity of the Merlin test in identifying sentinel lymph node biopsy status in high-risk patients with melanoma.

The rates of melanoma incidence have significantly declined since approximately 2015 in patients aged younger than 50 years while mortality also dropped in those aged younger than 60, according to a Swedish study.

While Black patients are less likely to develop first melanoma than white patients, this group has a higher relative rate of secondary melanoma diagnosis, according to a study.

Researchers confirmed that head and neck melanomas have distinct biological characteristics that make it more adverse to patients yet more responsive to immunotherapy, according to a study.

The addition of nivolumab to ipilimumab conferred a long-term OS benefit for patients with advanced melanoma, according to study results presented at ESMO Congress.

A “simple model” known as ATLAS can help physicians detect recurrent cutaneous melanoma through symptom review, according to researchers.

Researchers identified a gene signature that can predict which group of patients with melanoma will experience severe immune-related adverse events when treated with immune checkpoint inhibitor therapy, according to a study.

An immunotherapy combination improved outcomes compared with historical control for certain patients with advanced melanoma, according to a topline data announcement.

Patients with rosacea have an increased risk for malignant melanoma, joint problems, metabolic disease and visual disturbances, according to a study.